CAR-T Related Cytopenia Profile in Relapsed/Refractory Multiple Myeloma: Results of Patients Treated with ARI0002h, an Academic BCMA-Directed CAR-T Cell

被引：1

作者：

Oliver-Caldes, Aina ^{[1
]}

Gerardo Rodriguez-Lobato, Luis ^{[2
]}

Gonzalez-Calle, Veronica ^{[3
]}

Tovar, Natalia ^{[4
]}

Cabanas, Valentin ^{[5
]}

Rodriguez-Otero, Paula ^{[6
]}

Luis Reguera, Juan ^{[7
]}

Espanol-Rego, Marta ^{[8
]}

Martin-Antonio, Beatriz ^{[9
]}

Zabaleta, Aintzane ^{[10
]}

Lasa, Marta ^{[11
]}

Inoges, Susana ^{[11
]}

Lopez-Diaz de Cerio, Ascension ^{[11
]}

Paiva, Bruno ^{[12
]}

Varea, Sara ^{[13
]}

Saez-Penataro, Joaquin ^{[13
]}

Juan, Manel ^{[8
]}

Rosinol, Laura ^{[14
]}

Prosper, Felipe ^{[15
]}

Moraleda, Jose M. ^{[5
]}

Urbano-Ispizua, Alvaro ^{[16
]}

Pascal, Mariona ^{[8
]}

Mateos, Maria-Victoria ^{[17
]}

Fernandez de Larrea, Carlos ^{[2
]}

机构：

[1] Univ Barcelona, Dept Hematol, Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain

[2] Hosp Clin Barcelona, Dept Hematol, Amyloidosis & Myeloma Unit, Barcelona, Spain

[3] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain

[4] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Amyloidosis & Myeloma Unit, Barcelona, Spain

[5] Univ Murcia, IMIB Arrixaca, Hosp Clin Univ Virgen Arrixaca, Murcia, Spain

[6] Clin Univ Navarra, CIBER ONC, IDISNA, CCUN,CIMA, Pamplona, Navarra, Spain

[7] Univ Seville, Hosp Univ Virgen Rocio CSIC CIBERONC, UGC Hematol, Inst Biomed Sevilla IBiS, Seville, Spain

[8] Univ Barcelona, Dept Immunol, Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain

[9] Fdn Jimenez Diaz, Inst Invest Sanitaria, Madrid, Spain

[10] Univ Navarra, Clin Univ Navarra, Ctr Invest Med Aplicada, IDISNA,CIBERONC, Pamplona, Spain

[11] Clin Univ Navarra, Ctr Invest Med Aplicada CIMA, CIBERONC Pamplona, IDISNA, Pamplona, Spain

[12] Clin Univ Navarra, Canc Ctr Univ Navarra CCUN, Ctr Invest Med Aplicada CIMA, Inst Invest Sanitaria Navarra IDISNA, Pamplona, Navarra, Spain

[13] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Barcelona, Spain

[14] Hosp Clin Barcelona, IDIBAPS, Dept Hematol, Amyloidosis & Myeloma Unit, Barcelona, Spain

[15] Univ Navarra, Clin Univ Navarra, Ctr Invest Med Aplicada, Pamplona, Spain

[16] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[17] Univ Hosp Salamanca, IBSAL, Canc Res Ctr IBMCC USAL CSIC, Salamanca, Spain

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-166525

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：10347 / 10349

页数：3

共 50 条

[21] Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma
Han, Lu
Zhang, Ji-Shuai
Zhou, Jian
Zhou, Ke-Shu
Xu, Ben-Ling
Li, Lin-Lin
Fang, Bai-Jun
Yin, Qing-Song
Zhu, Xing-Hu
Zhou, Hu
Wei, Xu-Dong
Su, Hong-Chang
Zhang, Bing-Xiang
Wang, Ya-Nan
Xiang, Bin
Gao, Quan-Li
Song, Yong-Ping
LEUKEMIA, 2021, 35 (10) : 3002 - 3006
[22] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
Wang, Qingming
Wei, Runhong
Guo, Shufang
Min, Chao
Zhong, Xiong
Huang, Hui
Cheng, Zhi
CANCER GENE THERAPY, 2024, 31 (01) : 108 - 118
[23] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
Qingming Wang
Runhong Wei
Shufang Guo
Chao Min
Xiong Zhong
Hui Huang
Zhi Cheng
Cancer Gene Therapy, 2024, 31 : 420 - 426
[24] Prognostic markers for CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
Liu, Yang
Yan, Zhiling
Wu, Qingyun
Chen, Chong
Cao, Jiang
Li, Zhenyu
Xu, Kailin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S49 - S49
[25] T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
Battram, Anthony M.
Oliver-Caldes, Aina
Suarez-Lledo, Maria
Lozano, Miquel
Crespo, Miquel Bosch i
Martinez-Cibrian, Nuria
Cid, Joan
Moreno, David F.
Rodriguez-Lobato, Luis Gerardo
Urbano-Ispizua, Alvaro
de Larrea, Carlos Fernandez
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2022, 26 : 207 - 223
[26] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
He, Shao-long
Cheng, Yu-hang
Wang, Di
Xu, Meng-lei
Que, Yi-mei
Xu, Yan-jie
Ma, Liang-ming
Li, Chun-rui
Zhou, Jian-feng
CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
[27] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
Shao-long He
Yu-hang Cheng
Di Wang
Meng-lei Xu
Yi-mei Que
Yan-jie Xu
Liang-ming Ma
Chun-rui Li
Jian-feng Zhou
Current Medical Science, 2021, 41 : 474 - 481
[28] BCMA-directed CAR T-cell therapy in multiple myeloma
Cookson, Emma
LANCET HAEMATOLOGY, 2020, 7 (07): : E505 - E505
[29] CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey
Hakan, Goker
Engin, Kelkitli
Elifcan, Karakulak Aladag
Haluk, Demiroglu
Mehmet, Turgut
Suman, Kambhampati
Maxwell, Krem
FRONTIERS IN MEDICINE, 2024, 11
[30] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
Mei, Heng
Li, Chenggong
Jiang, Huiwen
Zhao, Xinying
Huang, Zhiping
Jin, Dan
Guo, Tao
Kou, Haiming
Liu, Lin
Tang, Lu
Yin, Ping
Wang, Zhihui
Ai, Lisha
Ke, Sha
Xia, Yimeng
Deng, Jun
Chen, Lei
Cai, Li
Sun, Chunyan
Xia, Linghui
Hua, Gaoquan
Hu, Yu
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)

← 1 2 3 4 5 →